We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Anti-Treponema Immunohistochemistry Cross-Reactivity Reported with Non-Treponema Spirochetes

By LabMedica International staff writers
Posted on 12 Oct 2016
Print article
Image: Immunohistochemical detection of human intestinal spirochetosis with signs of invasion (Photo courtesy of the US National Institute of Health).
Image: Immunohistochemical detection of human intestinal spirochetosis with signs of invasion (Photo courtesy of the US National Institute of Health).
Syphilis has different histopathologic presentations, and it can mimic a significant number of entities while human intestinal spirochetosis is characterized by the presence of a layer of spirochetes adherent to the apical epithelial surface of the colorectal mucosa.

The spirochete species most often associated with this finding in humans are Brachyspira pilosicoli and Brachyspira aalborgi. B.pilosicoli has been identified in other animals, such as pigs, rodents, and chickens, suggesting that the acquisition can be zoonotic. Higher prevalence rates are reported in developing countries, homosexual men, and human immunodeficient virus (HIV)-positive patients, who are also at increased risk for syphilis.

Medical scientists at the Cleveland Clinic (Cleveland, OH, USA) investigated the histopathologic findings of intestinal spirochetosis, which are different from those of syphilis. They used biopsies from eight patients with intestinal spirochetosis to evaluate the potential of cross-reactivity of a commercially available polyclonal antibody directed against Treponema pallidum, the causative agent of syphilis.

Hematoxylin-eosin stains and Warthin-Starry stains were available in all cases. The slides were reviewed and the diagnoses confirmed. In all biopsies, the hematoxylin-eosin–stained sections revealed a thickened and shaggy basophilic band on the apical cell membrane of the colorectal epithelium; Warthin-Starry stain demonstrated numerous spirochetes. Immunohistochemistry for T. pallidum (Biocare Medical, Concord, CA, USA) was performed on 2-μm sections of paraffin-embedded tissues, and the tissues were incubated 16 minutes at 37 °C. The protein-antibody complexes were located with the iView DAB Detection kit (Ventana Medical Systems, Oro Valley, AZ, USA). All biopsies showed strong positivity for the polyclonal antibody for T. pallidum.

The authors concluded that the potential for cross-reactivity of commercially available antibodies for T. pallidum with other spirochete species poses a potential diagnostic pitfall when biopsies are taken from locations wherein spirochetes may be encountered. The anti–T pallidum immunohistochemical stain remains a significant advance in the detection of T. pallidum spirochetes in the biopsies of patients with syphilis. It is important for the pathologist to be aware of this cross-reactivity with non-Treponema spirochetes. The histopathologic diagnosis of syphilis should not rest entirely on a positively staining spirochete. Rather, the diagnosis should be made based on the presence of the spirochetes with the appropriate histopathologic findings. The study was published in the October 2016 issue of the journal Archives of Pathology & Laboratory Medicine.

Related Links:
Cleveland Clinic
Biocare Medical
Ventana Medical Systems

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Pipet Controller
Stripettor Pro
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.